Drive success from drug discovery to commercialization
To combat the high cost and low success rates of drug development, you need solutions that turn data, analytics and expertise into intelligence that drives smarter commercialization decisions. With Definitive Healthcare Solutions for Biopharma, you can shorten time to market with informed decision-making and maximize the market potential of approved treatments.
Biopharma companies use our solutions to gain more credibility in the sector, more precisely target the right accounts and make decisions with more confidence.
Intelligence to power every phase of the drug development process
It’s no secret that therapy development is expensive and time-consuming. No matter where you are on the commercialization journey, we’ve got a solution that addresses your specific challenges. Our bundles are aligned with the FDA's drug development process. With the right healthcare commercial intelligence, you can assess the potential markets and segments, obtain real-time expert feedback and potentially bring your drug to market faster.
Chosen by the brands pioneering what's next
Answer your critical questions
Our Solutions for Biopharma empower you to make meaningful market decisions and find answers to important questions, such as:
Who are the medical and scientific experts with influence in your therapeutic area?
Who are the patients that need your drug?
Who are the providers who treat those patients, and where do they practice?
Decide with confidence
Definitive Healthcare Solutions for Biopharma can be used to:
Size potential markets
Quantify market size and total accessible patient populations with insights into network hierarchies.
Engage with experts
Target and prioritize the right medical experts, healthcare providers and scientists around the world to increase awareness, scientific credibility and influence.
Kickstart clinical trials
Leverage Medicare and commercial payor claims data with affiliation context to identify sites with high patient volumes and recruit investigators for clinical trials.
Identifying high-risk stroke patients
Discover how a leading cardiovascular division used our data to more accurately estimate, target and deliver their product to hospitals with the greatest number of high-risk stroke patients.